Supplement: First State Innovation

First State Innovation By Mike May ARTICLE EXTRAS A Region Defined Bridging the Gap Ben Franklin Technology Partners Keystone Innovation Zones NJIT's Enterprise Development Center Rowan University's CIE The Science Center Although well-known companies such as DuPont and AstraZeneca call Delaware their home, the state has lacked a reputation as a high-tech area. Consequently, Delaware has not always attracted new life science companies. "It s

Written byMike May
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A Region Defined

Bridging the Gap

Ben Franklin Technology Partners

Keystone Innovation Zones

NJIT's Enterprise Development Center

Rowan University's CIE

The Science Center

Although well-known companies such as DuPont and AstraZeneca call Delaware their home, the state has lacked a reputation as a high-tech area. Consequently, Delaware has not always attracted new life science companies. "It struggled to be successful in the entrepreneurial environment," says Ernest Dianastasis, managing director at Computer Aid, Inc. Toward the end of 2004, Dianastasis and a couple dozen business leaders focused on making Delaware a desirable home for life science entrepreneurs. Such an improvement would help the state, as well. "If we got the right group of people together," Dianastasis says, "I thought we could improve Delaware's economy."

After a quarter of a century of experience at Computer Aid, which solves information-technology problems for companies, Dianastasis knows how to tackle challenges. He grew that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies